News: Manufacturing

24 August 2022

Dexa Group Consistently Maintains Natural Ingredient Quality for Indonesian Phytopharmaceutical Products

Dexa Group, as a national pharmaceutical company, is committed to meeting the quality of Indonesian natural raw materials as the content of Indonesian Indigenous Modern Medicines, beginning with cultivation, harvesting, and post-harvest processes and continuing through the manufacturing process by Good Traditional Medicine Manufacturing standards (CPOTB). This is necessary to…
23 August 2021

Government Appreciates Industry 4.0 Implementation by Dexa Group

The Ministry of Industry continues to improve the competitiveness of the national industry through the transformation towards industry 4.0. In this regard, as a leading international pharmaceutical company in Indonesia, Dexa Group has implemented Industry 4.0 in the production process to distribution. President Director of PT Ferron Par Pharmaceuticals, Mr.…